STEXMEDOR Trademark

Trademark Overview

On Friday, January 28, 2005, a trademark application was filed for STEXMEDOR with the United States Patent and Trademark Office. The USPTO has given the STEXMEDOR trademark a serial number of 78555578. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 30, 2009. This trademark is owned by Bristol-Myers Squibb Company. The STEXMEDOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents
stexmedor

General Information

Serial Number78555578
Word MarkSTEXMEDOR
Filing DateFriday, January 28, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 30, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 7, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, March 30, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 30, 2009ABANDONMENT - NO USE STATEMENT FILED
Friday, July 25, 2008EXTENSION 5 GRANTED
Friday, July 25, 2008EXTENSION 5 FILED
Friday, July 25, 2008TEAS EXTENSION RECEIVED
Thursday, December 13, 2007EXTENSION 4 GRANTED
Thursday, December 13, 2007EXTENSION 4 FILED
Thursday, December 13, 2007TEAS EXTENSION RECEIVED
Monday, July 23, 2007EXTENSION 3 GRANTED
Monday, July 23, 2007EXTENSION 3 FILED
Monday, July 23, 2007TEAS EXTENSION RECEIVED
Wednesday, January 10, 2007EXTENSION 2 GRANTED
Wednesday, January 10, 2007EXTENSION 2 FILED
Wednesday, January 10, 2007TEAS EXTENSION RECEIVED
Monday, May 8, 2006EXTENSION 1 GRANTED
Monday, May 8, 2006EXTENSION 1 FILED
Monday, May 8, 2006TEAS EXTENSION RECEIVED
Tuesday, February 28, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2005PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2005NOTICE OF PUBLICATION
Thursday, October 13, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 7, 2005ASSIGNED TO LIE
Sunday, October 2, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 16, 2005EXAMINER'S AMENDMENT ENTERED
Wednesday, September 14, 2005EXAMINERS AMENDMENT MAILED
Wednesday, September 14, 2005EXAMINERS AMENDMENT -WRITTEN
Monday, August 29, 2005FINAL REFUSAL MAILED
Friday, August 26, 2005FINAL REFUSAL WRITTEN
Monday, August 22, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 13, 2005NON-FINAL ACTION MAILED
Wednesday, July 13, 2005NON-FINAL ACTION WRITTEN
Tuesday, July 12, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 30, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 30, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2005PRIORITY ACTION MAILED
Monday, April 25, 2005PRIORITY ACTION WRITTEN
Thursday, April 21, 2005ASSIGNED TO EXAMINER
Monday, February 7, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

stexmedor diseases pharmaceutical human preparations anti fungals antibiotics transplant organ virals